ReviewCurrent urology reports2013

The use of PDE-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

Casey Lythgoe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.